Multiply Labs · May 2026
Launched Multiply Labs Italia and named Enrico Racca as founding general manager to scale manufacturing for robotic clusters.
Robotic production capacity for the pharma manufacturing industry
Public company, workplace, funding, and market signals
San Francisco-based robotics company building modular biomanufacturing systems that automate advanced biologics and cell/gene therapy manufacturing for pharma customers, combining closed GMP robotics, process orchestration, and AI-driven simulation/autotraining.
Primary product
The Cluster modular robotic biomanufacturing system
Founded
2016
Headquarters
San Francisco, California, United States
Team size
60-70
Work style
Onsite
Industry
Robotics Engineering
Sub-industry
Cell and gene therapy manufacturing automation
Offices
6 jobs at Multiply Labs
Business model
Stage
Series A
Latest round
Series A · Apr 2023
Latest amount
$11.1M
Leadership
Co-Founder & CEO
Co-Founder & CSO
Manny Guerrero
CFO
VP, Business Ops & People
Chief Mfg & Supply Chain
Nadia Kreciglowa
Head of Robotic Software Engineering
Lisa Gonzalez
Head of Product
Max Rademacher
Head of System Software Engineering
Hanh Nguyen
Head of Quality
Founders
Joe Wilson
Mission-driven team of roboticists, scientists, and engineers in San Francisco focused on solving one of the hardest problems in biomanufacturing. The culture emphasizes robotics for good, fast iteration, and building advanced therapies that are accessible to more patients.
Work style
Onsite
Compensation
Public job postings signal startup-style compensation with significant equity components; no public salary bands were found.
Benefits
Pricing
B2B enterprise automation / robotics-as-a-service, sold through direct collaboration and deployment with therapy developers
Differentiators
Technology
Customers
Competitors
Estimated revenue
about $3.2M (LinkedIn company estimate)
Multiply Labs · May 2026
Launched Multiply Labs Italia and named Enrico Racca as founding general manager to scale manufacturing for robotic clusters.
Business Wire · Jan 2026
Announced a collaboration with AstraZeneca to evaluate GMP-ready robotic systems for commercial-scale cell therapy manufacturing.
Business Wire · Jan 2026
Announced work with NVIDIA using Isaac Sim, Omniverse, and GR00T for digital twins, perception, and robot training in biomanufacturing.
Multiply Labs · Sep 2025
Expanded partnership to automate Thermo Fisher's DynaCellect magnetic separation workflow and extend cell-therapy automation.
Multiply Labs · Jun 2025
Kyverna will evaluate automated manufacturing of KYV-102 using Multiply Labs' robotic systems and auto-training pipeline Resonance.